Governments across Canada are forcing patients with serious medical conditions to switch their medication to one that is similar but not the same, putting patients’ health and safety at risk. Find and write to your MPP/MLA and let them know you believe no patient should be forced to switch.
This survey is being conducted to learn from Canadians their experiences accessing specialty drugs. In addition, we are asking opinions about how specialty drugs should be available in a National Pharmacare program. This feedback is very important and timely.
On December 12, 2019, the Alberta government introduced the Alberta Biosimilar Initiative. This communication is to inform you the switching requirement of the Biosimilar Initiative.
